Daily Archives: September 10, 2020

Stevie® Awards Announce Winners in 17th Annual International Business Awards® from Across the Globe

Businesses Honored for Achievements Amidst COVID-19

Winners announced in The 2020 International Business Awards

Gold, Silver, and Bronze Stevie winners were selected from more than 3,800 nominations. “Given the extraordinary circumstances in which businesses and other organizations around the world have operated over the past six months, we’re gratified by the number of entries the IBAs received this year and the amazing number of stories of continued business success.”

FAIRFAX, Va., Sept. 10, 2020 (GLOBE NEWSWIRE) — High-achieving organizations and executives around the world have been recognized as Gold, Silver, and Bronze Stevie® Award winners in The 17th Annual International Business Awards®, the world’s only international, all-encompassing business awards program.

Winners were selected from more than 3,800 nominations submitted by organizations in more than 60 nations.

More than 250 executives worldwide participated on 13 juries to determine the Stevie winners.

The top winner of Gold, Silver, and Bronze Stevies overall is Turkey’s Yapı Kredi Bank, with 20.  Other multiple winners of note are LLYC (18), Ooredoo Group (16), Thai Life Insurance (14), PJ Lhuillier, Inc (13), Jeunesse Global (12), Makers Nutrition (12), Melco Resorts & Entertainment (10), and Türkiye İş Bankası (10).

LLYC, a global communications and public affairs consulting firm headquartered in Madrid, Spain won nine Gold Stevie Awards, more than any other organization in the competition.

All organizations worldwide are eligible to compete in the IBAs, and can submit entries in a wide range of categories for achievement in management, marketing awards, public relations, customer service, human resources, new products, technology, web sites, apps, events, and more.

This year’s competition featured a range of free-to-enter COVID-19 Response categories to recognize the contributions of organizations and individuals.  Stevie winners in these categories include Better2Know, CareAline Products, Diagnostic Robotics, Facebook India, Howard University, HP Inc., IBM, Mater, Multifly KFT., NCR Corporation, Shift3 Technologies, and Trinity Services, among others.

A complete list of all 2020 Gold, Silver and Bronze Stevie Award winners by category is available at www.StevieAwards.com/IBA.

The awards will be presented during a virtual awards ceremony on Tuesday, December 1.

About the Stevie® Awards
Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Great Employers, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

Contact
Nina Moore
Nina@StevieAwards.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f0d8b048-b6f7-4ee6-a0c0-046eb93478c7

New CLHS cameras engineered for true high-performance image capture

Teledyne DALSA expands the Falcon4-CLHS camera portfolio with high-performance Teledyne e2v Lince 11.2M CMOS sensors

Teledyne DALSA’s Falcon4-CLHS camera

The Falcon4-CLHS camera incorporates very large resolutions and faster frame rates for improved image quality

WATERLOO, Ontario, Sept. 10, 2020 (GLOBE NEWSWIRE) — Teledyne DALSA, a Teledyne Technologies [NYSE:TDY] company and global leader in machine vision, is pleased to announce its new Falcon4-CLHS M4480 and M4400, based on the Teledyne e2v Lince 11.2M monochrome sensors. The new Falcon4-CLHS models deliver easy-to-use, CLHS interface cameras that have been specifically engineered for industrial imaging applications requiring high-speed data transfer. These models can reach multiple thousands of frames per second in partial scan mode, and when using the sensor’s binning mode, can reach a very large pixel full well capacity of over 160Ke.

“The new Teledyne e2v Lince 11.2M CMOS image sensors provide excellent performance and image quality for any machine vision applications that require true high-performance imaging,” said Manny Romero, Senior Product Manager at Teledyne DALSA. “With the addition of these latest Falcon4-CLHS models, we are now pleased to offer a variety of cameras ranging from the high-speed 11.2 M camera with a frame rate up to 609 fps in full resolution, to the high-resolution 86 MP camera with a frame rate up to 16 fps.

The Falcon4-CLHS leverages standard cabling technology such as CX4 and fiber optic (AOC) cables to maximize length and speed. Falcon4-CLHS cameras are engineered to deliver high-speed, dependable results for applications such as machine vision industrial automation, flat panel display inspection, semiconductor inspection, PCB-AOI (Automated Optical Inspection), aerial imaging, and general machine vision applications that require true high-performance imaging.

Key Features:

  • Two new models are offered in 11.2M monochrome versions
  • Large full well capacity when using in-sensor binning >160Ke
  • Thousands of frames per second in Partial Scan Mode (ROI)
  • Series supports advanced high-performance camera features in a compact form factor for easy integration
  • Additional models planned with resolutions over 100M
  • All-metal body with 3-year warranty

For more information about the Falcon4-CLHS models visit the website. For high quality images, please visit our online media kit.

Teledyne DALSA is part of the Teledyne Imaging group and a world leader in the design, manufacture and deployment of digital imaging components for the machine vision market. Teledyne DALSA image sensors, cameras, smart cameras, frame grabbers, software, and vision solutions are used in thousands of automated inspection systems around the world and across multiple industries including semiconductor, solar cell, flat panel display, electronics, automotive, medical, packaging and general manufacturing. For more information, visit www.teledynedalsa.com/mv.

Teledyne Imaging is a group of leading-edge companies aligned under the Teledyne umbrella. Teledyne Imaging forms an unrivalled collective of expertise across the spectrum with decades of experience. Individually, each company offers best-in-class solutions. Together, they combine and leverage each other’s strengths to provide the deepest, widest imaging and related technology portfolio in the world. From aerospace through industrial inspection, scientific research, spectroscopy, radiography and radiotherapy, geospatial surveying, and advanced MEMS and semiconductor solutions, Teledyne Imaging offers worldwide customer support and the technical expertise to handle the toughest tasks. Their tools, technologies, and vision solutions are built to deliver to their customers a unique and competitive advantage.

All trademarks are registered by their respective companies.
Teledyne DALSA reserves the right to make changes at any time without notice.

Contact:
Brooks Riendeau, Vice President of Marketing
613-736-4077 ext. 120
brooks.riendeau@teledyne.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4f9e6eb8-b067-465f-b812-3ec3ceed2cdf

Novavax to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Sept. 10, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will participate in five upcoming investor conferences. A topic of discussion will be Novavax’ COVID-19 vaccine candidate, NVX-CoV2373.

Conference details are as follows:

Citi 15th Annual BioPharma Virtual Conference

Date: September 10, 2020
Event: Investor meetings only

H.C. Wainwright 22nd Annual Global Investment Conference

Date: September 14, 2020
Time: 9:30 a.m. U.S. Eastern Time (ET)
Event: Corporate presentation and investor meetings
Live Webcast: www.novavax.com, “Investors”/ “Events”

Cantor Virtual Global Healthcare Conference

Date: September 15, 2020
Time: 11:20 a.m. U.S. Eastern Time (ET)
Event: Fireside chat and investor meetings
Live Webcast: www.novavax.com, “Investors”/ “Events”

Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Date: September 16, 2020
Time: 12:30 p.m. U.S. Eastern Time (ET)
Event: Fireside chat and investor meetings
Live Webcast: www.novavax.com, “Investors”/ “Events”

Leerink CyberRx Series: Vaccine Forum

Date: September 23, 2020
Time: 9:00 a.m. U.S. Eastern Time (ET)
Event: Fireside chat

A replay of the presentations will also be accessible under the “Investors/Events” section www.novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax is undergoing clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

For more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.

Contacts:
Investors
Silvia Taylor and Erika Trahan
ir@novavax.com
240-268-2022

Media
Brandzone/KOGS Communication
Edna Kaplan
kaplan@kogspr.com
617-974-8659

Berkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Berkeley Lights Platform for cell line development. Berkeley Lights, Inc., (Nasdaq: BLI), a leader in Digital Cell Biology, continues to see adoption of the system in Asia Pacific, as Mycenax becomes the first company in Taiwan to use the technology.

“At Mycenax, we strive to be a leader in comprehensive biologics development with the highest standards of technology and manufacturing,” said Pei-Jiun Chen, Ph.D., CEO of Mycenax. “We are excited to work with the Berkley Lights team to enhance our existing services, and we believe the Beaconsystem enables a big jump to the next level of success in cell line development.”

Mycenax develops high-quality cell lines from many different cell types and is transferring their cell line development process for each of these onto the BeaconOptofluidic System utilizing Berkley Lights Opto™ Cell Line Development workflow. The Beacon system helps Mycenax increase efficiency and flexibility and enhance the quality of its cell line development services for its customers. With the proven reputation of its cell line generation services and its first-in-class R&D team, Mycenax is implementing the Beacon system to find rare, high productivity clones with industry leading monoclonality while shortening its overall timeline for cell line development up to 50%.

“In a time of rapid growth for the biopharmaceutical industry in Asia Pacific and around the globe, we’re excited to have Mycenax adopt the Berkeley Lights Platform,” said Eric Hobbs, Ph.D., CEO of Berkeley Lights. “Our Opto™ Cell Line Development workflows will enable Mycenax to generate the best cell lines for complex antibody therapeutics with unrivaled clonality assurance in less than one week for their customers.”

About Mycenax
Founded in September 2001, Mycenax Biotech is the pioneer in Taiwan focusing on the CMC development and GMP production of biologics. The company encompasses a complete value chain, ranging from cell line, process and formulation developments, GMP production and fill-finish, through its high-standard biologics development technology and PIC/S GMP certified manufacturing facility. Utilizing Taiwan as the center for development and manufacturing, Mycenax integrates the up- and downstream of the industry to offer contract development and manufacturing services.

Media Contact
Alvan Chou
alvan.chou@mycenax.com.tw

About Berkeley Lights
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley LightsBeacon and Lightning™ systems and Culture Station™ instrument are FOR RESEARCH USE ONLY.  Not for use in diagnostic procedures.

Press Contact
berkeleylights@bulleitgroup.com

Investor Contact
ir@berkeleylights.com